S, F., SF, H., J, C., YA, W., LP, Z., & GS, R. (2013). Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression. Clinical and experimental medicine, 13(2), 127. https://doi.org/10.1007/s10238-012-0182-9
Chicago Style (17th ed.) CitationS, Fang, Huang SF, Cao J, Wen YA, Zhang LP, and Ren GS. "Silencing of PCDH10 in Hepatocellular Carcinoma via De Novo DNA Methylation Independent of HBV Infection or HBX Expression." Clinical and Experimental Medicine 13, no. 2 (2013): 127. https://doi.org/10.1007/s10238-012-0182-9.
MLA (9th ed.) CitationS, Fang, et al. "Silencing of PCDH10 in Hepatocellular Carcinoma via De Novo DNA Methylation Independent of HBV Infection or HBX Expression." Clinical and Experimental Medicine, vol. 13, no. 2, 2013, p. 127, https://doi.org/10.1007/s10238-012-0182-9.